Toronto Dominion Bank
WST icon

Toronto Dominion Bank’s West Pharmaceutical WST Stock Holding History

Toronto Dominion Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-500
Closed -$125K – 2437
2025
Q4 		$125K Buy
+500
New +$137K ﹤0.01% 1532

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toronto Dominion Bank's WST Position: Q1 2026 in Review

Toronto Dominion Bank reduced its West Pharmaceutical (WST) stake by 12% in Q1 2026, selling an estimated $701K and leaving 21,221 shares worth $5.32M. The position accounts for 0.01% of the portfolio, ranked #831.

Toronto Dominion Bank first reported a position in WST in Q1 2016 and has held it in 35 quarters since. The position peaked at $23.3M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Toronto Dominion Bank held 21,221 shares of West Pharmaceutical worth $5.32M as of Q1 2026.
  • Toronto Dominion Bank sold 2,816 West Pharmaceutical shares in Q1 2026, an estimated $701K.
  • West Pharmaceutical made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #831 holding.
  • Toronto Dominion Bank first reported a position in West Pharmaceutical in Q1 2016 and has held it in 35 quarters since.
  • Toronto Dominion Bank's West Pharmaceutical position peaked at $23.3M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.